Onyda Xr — amphetamine class
Named-patient access overview. Onyda Xr is coordinated by Reserve Meds for international patients via physician-led cross-border sourcing.
About Onyda Xr
Onyda XR (amphetamine class) is manufactured by TBD – verify (Rhodes/Purdue?) and indicated for ADHD stimulant ER — OUT OF SCOPE (amphetamine class, DEA Schedule II; PlatformCo does not handle controlled substances. Fatima's DEA-registered entity may pursue separately.). It is a unverified approved by the US FDA in unverified and may be accessible to international patients through Named Patient Program or personal-import pathways.
How Reserve Meds coordinates Onyda Xr
- Patient or treating physician submits a named-patient request.
- Clinical team verifies appropriateness of Onyda Xr for the patient and destination country.
- Treating physician issues prescription and clinical justification.
- Country-specific NPP / personal-import documentation is prepared.
- Onyda Xr is sourced from a DSCSA-compliant US specialty wholesaler with full serial traceability.
- Shipment is coordinated to the patient's physician or hospital pharmacy (cold-chain where required).
Access by country
We have documented named-patient access pathways for Onyda Xr in the countries below. Each page outlines the destination-country regulatory posture, typical timeline, and physician-credential requirements.
Start a request for Onyda Xr
Submit a 60-second intake. Our clinical team responds within one business day with case-specific feasibility, timeline, and a formal quote.